Long-Time Horizon Analysis of AIM ImmunoTech Inc (AIM) Stock

AIM ImmunoTech Inc [AIM] stock is trading at $0.12, up 2.75%. An important factor to consider is whether the stock is rising or falling in short-term value. The AIM shares have lost -0.40% over the last week, with a monthly amount drifted -38.88%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

AIM ImmunoTech Inc [AIM] stock has fluctuated between $0.11 and $0.62 over the past year. AIM ImmunoTech Inc [AMEX: AIM] shares were valued at $0.12 at the most recent close of the market.

Analyzing the AIM fundamentals

AIM ImmunoTech Inc [AMEX:AIM] reported sales of 0.19M for the trailing twelve months, which represents a drop of -23.91%. Gross Profit Margin for this corporation currently stands at 0.2% with Operating Profit Margin at -146.88%, Pretax Profit Margin comes in at -125.94%, and Net Profit Margin reading is -125.94%. To continue investigating profitability, this company’s Return on Assets is posted at -1.76, Equity is -3.98 and Total Capital is -8.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.17.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1138 points at the first support level, and at 0.1041 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1320, and for the 2nd resistance point, it is at 0.1405.

Ratios To Look Out For

For context, AIM ImmunoTech Inc’s Current Ratio is 0.75. On the other hand, the Quick Ratio is 0.75, and the Cash Ratio is 0.09. Considering the valuation of this stock, the price to sales ratio is 44.67, the price to book ratio is 2.49.

Transactions by insiders

Recent insider trading involved Equels Thomas K, CEO & President, that happened on Mar 04 ’25 when 83334.0 shares were purchased. CEO & President, Equels Thomas K completed a deal on Nov 21 ’24 to buy 20000.0 shares. Meanwhile, Director MITCHELL WILLIAM M sold 4580.0 shares on Dec 19 ’24.

Related Posts